{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:12:08Z","timestamp":1793747528452,"version":"4.6.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/ico.0b013e31823f8f7a","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T06:41:03Z","timestamp":1329979263000},"page":"887-892","source":"Crossref","is-referenced-by-count":71,"title":["Angioregressive Pretreatment of Mature Corneal Blood Vessels Before Keratoplasty"],"prefix":"10.1097","volume":"31","author":[{"given":"Yanyan","family":"Koenig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich E.","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":". Corneal neovascularization.","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-9-20210204","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00347-007-1512-2","article-title":". Inhibition of angiogenesis in the anterior chamber of the eye.","volume":"104","author":"Bock","year":"2007","journal-title":"Ophthalmologe"},{"key":"R3-9-20210204","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","article-title":". Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-9-20210204","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases.","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"R5-9-20210204","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":". Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"R6-9-20210204","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":". Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization.","volume":"247","author":"Koenig","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R7-9-20210204","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","article-title":". Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation.","volume":"87","author":"Cursiefen","year":"2003","journal-title":"Br J Opththalmol"},{"key":"R8-9-20210204","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels.","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-9-20210204","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00003226-198906000-00012","article-title":"The limbal vascular response to corneal injury. An autoradiographic study.","volume":"8","author":"Junghans","year":"1989","journal-title":"Cornea"},{"key":"R10-9-20210204","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","article-title":". Bevacizumab (Avastin) eye drops inhibit corneal neovascularization.","volume":"246","author":"Bock","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-9-20210204","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.exer.2008.08.007","article-title":". Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts.","volume":"87","author":"Bock","year":"2008","journal-title":"Exp Eye Res"},{"key":"R12-9-20210204","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-9-20210204","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00003226-200007000-00025","article-title":"Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization.","volume":"19","author":"Cursiefen","year":"2000","journal-title":"Cornea"},{"key":"R14-9-20210204","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":". Topical bevacizumab in the treatment of corneal neovascularisation: results of a prospective, open-label, noncomparative study.","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R15-9-20210204","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":". Subconjunctival bevacizumab injection for corneal neovascularization.","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"R16-9-20210204","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00003226-200307000-00018","article-title":". Photodynamic therapy of corneal neovascularization with verteporfin.","volume":"22","author":"Fossarello","year":"2003","journal-title":"Cornea"},{"key":"R17-9-20210204","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/ICO.0b013e318180e50f","article-title":"Bevacizumab (avastin) and argon laser to treat neovascularization in corneal transplant surgery.","volume":"27","author":"Gerten","year":"2008","journal-title":"Cornea"},{"key":"R18-9-20210204","first-page":"323","article-title":". Binding of basic fibroblast growth factor to normal and neovascularized rabbit cornea.","volume":"31","author":"Soubrane","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-9-20210204","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis.","volume":"117","author":"Bachmann","year":"2010","journal-title":"Ophthalmology"},{"key":"R20-9-20210204","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.0903180","article-title":". Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation.","volume":"184","author":"Dietrich","year":"2010","journal-title":"J Immunol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-201208000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:32:21Z","timestamp":1785767541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-201208000-00009"}},"subtitle":["Fine-Needle Vessel Coagulation Combined With Anti-VEGFs"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31823f8f7a","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}